Sugammadex: Efficacy and Practicality in the Dental Office.

Anesth Prog

Assistant Professor, Section of Dental/Maxillofacial Anesthesiology, The Ohio State University College of Dentistry, Columbus, Ohio.

Published: October 2019

Sugammadex is a novel drug capable of reversing paralysis induced by the common steroidal nondepolarizing neuromuscular blocking drugs, rocuronium and vecuronium. Reversal is complete at any depth of blockade dependent on the dose of sugammadex administered. This allows rocuronium to be used as a rescue agent in scenarios where succinylcholine is contraindicated. Sugammadex is considered a safe drug with minimal side effects compared with traditional reversal with neostigmine and glycopyrrolate. This article features a case report where succinylcholine was undesirable and rapid reversal of paralysis with sugammadex was used during general anesthesia for dentistry.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022787PMC
http://dx.doi.org/10.2344/anpr-65-03-03DOI Listing

Publication Analysis

Top Keywords

sugammadex
5
sugammadex efficacy
4
efficacy practicality
4
practicality dental
4
dental office
4
office sugammadex
4
sugammadex novel
4
novel drug
4
drug capable
4
capable reversing
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!